Global Bispecific Antibody Molecular Drug Market Research Report 2024(Status and Outlook)

Global Bispecific Antibody Molecular Drug Market Research Report 2024(Status and Outlook)



Report Overview:

Bispecific antibody molecular drugs are developed on the basis of monoclonal antibodies and are regarded as the second-generation antibody therapy for tumor treatment. Bispecific antibody molecules do not exist in the natural state and can only be prepared artificially. Its development is through the co-expression of two different H chains and two different L chains. Therefore, bispecific antibodies can specifically bind 2 different antigens.

The Global Bispecific Antibody Molecular Drug Market Size was estimated at USD 536.13 million in 2023 and is projected to reach USD 804.59 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.

This report provides a deep insight into the global Bispecific Antibody Molecular Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bispecific Antibody Molecular Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bispecific Antibody Molecular Drug market in any manner.

Global Bispecific Antibody Molecular Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

MacroGenics

Xencor

Medimmune

Merrimsck

Merus NV

Genentech

Zhongshan Kangfang Biology Medicine

Sichuan Baili Pharmaceutical

Alphamab Oncology

Amgen

Market Segmentation (by Type)

EGFR×HER3 Target

PD-1×CTLA-4 Target

HER2×HER3 Target

Market Segmentation (by Application)

Pancreatic Cancer

Breast Cancer

Colorectal Cancer

Non-Small Cell Lung Cancer

Solid Tumor

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Bispecific Antibody Molecular Drug Market
  • Overview of the regional outlook of the Bispecific Antibody Molecular Drug Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bispecific Antibody Molecular Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bispecific Antibody Molecular Drug
1.2 Key Market Segments
1.2.1 Bispecific Antibody Molecular Drug Segment by Type
1.2.2 Bispecific Antibody Molecular Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bispecific Antibody Molecular Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Bispecific Antibody Molecular Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bispecific Antibody Molecular Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bispecific Antibody Molecular Drug Market Competitive Landscape
3.1 Global Bispecific Antibody Molecular Drug Sales by Manufacturers (2019-2024)
3.2 Global Bispecific Antibody Molecular Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Bispecific Antibody Molecular Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bispecific Antibody Molecular Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bispecific Antibody Molecular Drug Sales Sites, Area Served, Product Type
3.6 Bispecific Antibody Molecular Drug Market Competitive Situation and Trends
3.6.1 Bispecific Antibody Molecular Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bispecific Antibody Molecular Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bispecific Antibody Molecular Drug Industry Chain Analysis
4.1 Bispecific Antibody Molecular Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bispecific Antibody Molecular Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bispecific Antibody Molecular Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bispecific Antibody Molecular Drug Sales Market Share by Type (2019-2024)
6.3 Global Bispecific Antibody Molecular Drug Market Size Market Share by Type (2019-2024)
6.4 Global Bispecific Antibody Molecular Drug Price by Type (2019-2024)
7 Bispecific Antibody Molecular Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bispecific Antibody Molecular Drug Market Sales by Application (2019-2024)
7.3 Global Bispecific Antibody Molecular Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Bispecific Antibody Molecular Drug Sales Growth Rate by Application (2019-2024)
8 Bispecific Antibody Molecular Drug Market Segmentation by Region
8.1 Global Bispecific Antibody Molecular Drug Sales by Region
8.1.1 Global Bispecific Antibody Molecular Drug Sales by Region
8.1.2 Global Bispecific Antibody Molecular Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Bispecific Antibody Molecular Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bispecific Antibody Molecular Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bispecific Antibody Molecular Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bispecific Antibody Molecular Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bispecific Antibody Molecular Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 MacroGenics
9.1.1 MacroGenics Bispecific Antibody Molecular Drug Basic Information
9.1.2 MacroGenics Bispecific Antibody Molecular Drug Product Overview
9.1.3 MacroGenics Bispecific Antibody Molecular Drug Product Market Performance
9.1.4 MacroGenics Business Overview
9.1.5 MacroGenics Bispecific Antibody Molecular Drug SWOT Analysis
9.1.6 MacroGenics Recent Developments
9.2 Xencor
9.2.1 Xencor Bispecific Antibody Molecular Drug Basic Information
9.2.2 Xencor Bispecific Antibody Molecular Drug Product Overview
9.2.3 Xencor Bispecific Antibody Molecular Drug Product Market Performance
9.2.4 Xencor Business Overview
9.2.5 Xencor Bispecific Antibody Molecular Drug SWOT Analysis
9.2.6 Xencor Recent Developments
9.3 Medimmune
9.3.1 Medimmune Bispecific Antibody Molecular Drug Basic Information
9.3.2 Medimmune Bispecific Antibody Molecular Drug Product Overview
9.3.3 Medimmune Bispecific Antibody Molecular Drug Product Market Performance
9.3.4 Medimmune Bispecific Antibody Molecular Drug SWOT Analysis
9.3.5 Medimmune Business Overview
9.3.6 Medimmune Recent Developments
9.4 Merrimsck
9.4.1 Merrimsck Bispecific Antibody Molecular Drug Basic Information
9.4.2 Merrimsck Bispecific Antibody Molecular Drug Product Overview
9.4.3 Merrimsck Bispecific Antibody Molecular Drug Product Market Performance
9.4.4 Merrimsck Business Overview
9.4.5 Merrimsck Recent Developments
9.5 Merus NV
9.5.1 Merus NV Bispecific Antibody Molecular Drug Basic Information
9.5.2 Merus NV Bispecific Antibody Molecular Drug Product Overview
9.5.3 Merus NV Bispecific Antibody Molecular Drug Product Market Performance
9.5.4 Merus NV Business Overview
9.5.5 Merus NV Recent Developments
9.6 Genentech
9.6.1 Genentech Bispecific Antibody Molecular Drug Basic Information
9.6.2 Genentech Bispecific Antibody Molecular Drug Product Overview
9.6.3 Genentech Bispecific Antibody Molecular Drug Product Market Performance
9.6.4 Genentech Business Overview
9.6.5 Genentech Recent Developments
9.7 Zhongshan Kangfang Biology Medicine
9.7.1 Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Basic Information
9.7.2 Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Product Overview
9.7.3 Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Product Market Performance
9.7.4 Zhongshan Kangfang Biology Medicine Business Overview
9.7.5 Zhongshan Kangfang Biology Medicine Recent Developments
9.8 Sichuan Baili Pharmaceutical
9.8.1 Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Basic Information
9.8.2 Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Product Overview
9.8.3 Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Product Market Performance
9.8.4 Sichuan Baili Pharmaceutical Business Overview
9.8.5 Sichuan Baili Pharmaceutical Recent Developments
9.9 Alphamab Oncology
9.9.1 Alphamab Oncology Bispecific Antibody Molecular Drug Basic Information
9.9.2 Alphamab Oncology Bispecific Antibody Molecular Drug Product Overview
9.9.3 Alphamab Oncology Bispecific Antibody Molecular Drug Product Market Performance
9.9.4 Alphamab Oncology Business Overview
9.9.5 Alphamab Oncology Recent Developments
9.10 Amgen
9.10.1 Amgen Bispecific Antibody Molecular Drug Basic Information
9.10.2 Amgen Bispecific Antibody Molecular Drug Product Overview
9.10.3 Amgen Bispecific Antibody Molecular Drug Product Market Performance
9.10.4 Amgen Business Overview
9.10.5 Amgen Recent Developments
10 Bispecific Antibody Molecular Drug Market Forecast by Region
10.1 Global Bispecific Antibody Molecular Drug Market Size Forecast
10.2 Global Bispecific Antibody Molecular Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bispecific Antibody Molecular Drug Market Size Forecast by Country
10.2.3 Asia Pacific Bispecific Antibody Molecular Drug Market Size Forecast by Region
10.2.4 South America Bispecific Antibody Molecular Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bispecific Antibody Molecular Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Bispecific Antibody Molecular Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bispecific Antibody Molecular Drug by Type (2025-2030)
11.1.2 Global Bispecific Antibody Molecular Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bispecific Antibody Molecular Drug by Type (2025-2030)
11.2 Global Bispecific Antibody Molecular Drug Market Forecast by Application (2025-2030)
11.2.1 Global Bispecific Antibody Molecular Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Bispecific Antibody Molecular Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings